Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing

Benzinga02:13

Barclays Remains a Hold on GlaxoSmithKline (GSK)

TipRanksDec 12 15:35 · Ratings

Anaptys Scraps Development of ANB032, Stock Plunges 33%

Seeking AlphaDec 12 00:52

TD Cowen Maintains GlaxoSmithKline(GSK.US) With Hold Rating, Maintains Target Price $45

Futu NewsDec 11 23:32 · Ratings

GSK Stock Declines 20% in 3 Months: Should You Buy, Sell or Hold?

Zacks Dec 11 22:30

Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

TipRanksDec 11 20:35 · Ratings